EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RFWD2 Mitigates AD ‐Like Cognitive Impairments via the JNK – SGK1 Signaling Pathway in Mice

Mengjiao Ying iD, Xiaochuan Qi iD, Ao Wang iD, Guangshang Zhong, Wenhui Tong iD, Danting Yu, Gaofeng Liu, Yu Guo iD

CNS Neuroscience & Therapeutics · 2026-04 · 32 (4)

DOI: 10.1002/cns.70860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 09.04.2026. Verfasst von Mengjiao Ying und 7 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Provincial Center for Neural Regeneration Technology and New Medical Materials Engineering Research, Bengbu Medical University, Bengbu, Anhui, …. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Immediate-Early Proteins, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Anhui Province, Science Research Project of Bengbu Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer disease (AD) is a degenerative disorder of the central nervous system. Its main pathological feature is the formation of neurofibrillary tangles through abnormal β‐amyloid protein (Aβ) aggregation and excessive Tau protein phosphorylation. Ring finger and WD repeating domain 2 (RFWD2) is an E3 ubiquitin ligase that regulates neuronal dendrite complexity through the c‐Jun N‐terminal kinase (JNK) pathway. This study aimed to investigate the regulatory effect of RFWD2 on the downstream protein, serum/glucocorticoid‐regulated kinase 1 (SGK1), through the JNK pathway and explore its influence on AD pathogenesis.

Methods

Cognitive‐level behavioral detection was performed in RFWD2 +/− mice. Cultured PC12 cells and cortical neurons were also used to analyze the changes in signaling pathways caused by the decreased expression of RFWD2 in vitro and correlations between the expression of related proteins and key signaling pathways of AD at the molecular level.

Results

Decreased RFWD2 expression led to cognitive deficits in AD mice, resulting in mitochondrial swelling, fragmentation of hippocampal neurons, abnormally high reactive oxygen species levels, and an imbalance between antiapoptotic and proapoptotic proteins. This effect was significantly improved by inhibiting the JNK pathway and SGK1 protein expression. Furthermore, in vitro experiments showed that in PC12 cells and cortical neurons downregulated by RFWD2, the expression levels of p‐JNK, SGK1, and p‐Tau increased, and those of LC3B/Beclin‐1 decreased; ROS levels increased, and apoptosis was induced; inhibiting JNK or SGK1 expression reversed these changes.

Conclusion

RFWD2 regulates SGK1 expression through the JNK pathway, thereby regulating mitochondrial autophagy and apoptosis, altering the expression levels of p‐Tau and Aβ proteins, inducing AD‐like symptoms in mice, and promoting AD development. The RFWD2–JNK–SGK1 axis provides a valuable basis for studying the mechanisms of AD occurrence and developing early intervention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesImmediate-Early ProteinsAlzheimer DiseaseCognitive DysfunctionMAP Kinase Signaling SystemUbiquitin-Protein LigasesAnimalsSerum-Glucocorticoid Regulated KinasesMicePC12 CellsRatsMaleSignal TransductionNeuronsMice, Inbred C57BLHippocampus

Stichwörter der Autor:innen

Alzheimer diseaseJNK pathwayRFWD2SGK1cognitive function

Substanzen

Serum-Glucocorticoid Regulated KinasesProtein Serine-Threonine KinasesImmediate-Early ProteinsUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Anhui Provincial Center for Neural Regeneration Technology and New Medical Materials Engineering Research, Bengbu Medical University, Bengbu, Anhui, China.
  • School of Life Sciences, Bengbu Medical University, Bengbu, Anhui, China.
  • School of Laboratory Medicine, Bengbu Medical University, Bengbu, Anhui, China.
  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Pathology, Jinan, Shandong, China.

ORCID-Profile: Mengjiao Ying, Xiaochuan Qi, Ao Wang, Wenhui Tong, Yu Guo

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Anhui Province
  • Science Research Project of Bengbu Medical University
  • Postgraduate Innovative Training Program of Bengbu Medical University
  • Undergraduate Innovative Training Program of China

Zitieren

APA

Ying, M., Qi, X., Wang, A., Zhong, G., Tong, W., Yu, D., Liu, G., & Guo, Y. (2026). RFWD2 Mitigates AD ‐Like Cognitive Impairments via the JNK – SGK1 Signaling Pathway in Mice. CNS Neuroscience & Therapeutics, 32(4). https://doi.org/10.1002/cns.70860

Vancouver

Ying M, Qi X, Wang A, Zhong G, Tong W, Yu D, et al. RFWD2 Mitigates AD ‐Like Cognitive Impairments via the JNK – SGK1 Signaling Pathway in Mice. CNS Neuroscience & Therapeutics. 2026;32(4). doi:10.1002/cns.70860

BibTeX
@article{Ying2026,
  author = {Ying, Mengjiao and Qi, Xiaochuan and Wang, Ao and Zhong, Guangshang and Tong, Wenhui and Yu, Danting and Liu, Gaofeng and Guo, Yu},
  title = {RFWD2 Mitigates AD ‐Like Cognitive Impairments via the JNK – SGK1 Signaling Pathway in Mice},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {4},
  doi = {10.1002/cns.70860}
}
Kostenlos starten →